|
NVIDIA Crushed Expectations
NVDA crushed expectations last night with record revenue of $57 billion (up 62% year-over-year) and strong forward guidance, driven by insatiable demand for its new Blackwell AI chips.
-
For the broader sector, these results serve as a critical reassurance that the AI infrastructure boom is far from over.
-
Effectively dispelling near-term fears of an "AI bubble" and confirming that major tech companies are continuing to spend aggressively on hardware.
|
| Get Live Market Updates - 8:30 AM ET |
|
Exact Sciences (EXAS) Stock Surge and Acquisition Rumors
Shares of Exact Sciences (EXAS) jumped nearly 24% on Wednesday following reports that the major healthcare company, Abbott Laboratories, is in advanced talks to buy the company.
-
In the financial world, this is known as an acquisition or a buyout
-
When a large company wants to buy a smaller one, they usually offer a price higher than the current market value (a "premium") to convince shareholders to sell.
Investors rushed to buy EXAS stock immediately after the news broke, hoping to profit from this potential higher buyout price, which caused the sudden spike in the stock's value. |
|
EXAS: Speculation vs. Reality
For traders, the impact of this news is significant but carries high risk. Since the deal is currently just a rumor and has not been officially confirmed, this is considered "speculative trading."
If the companies fail to reach an agreement, the stock price could crash back down just as quickly as it rose. Additionally, because the price has already risen by 24%, most of the profit from the potential deal is likely already reflected in the price.
Therefore, buying the stock now is risky, as there is no guarantee the deal will happen. |
|
|
 |
|
Live Trading: AI Sector Tested, Is it Still Alive?
| | | |